FDA-Drug2019-06-26Class II
MethylPREDNISolone Tablets, USP 8 mg, 25 tablets, Rx Only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India NDC 68382-917-11
Zydus Pharmaceuticals USA Inc
Hazard
CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Sold states
Nationwide in the USA
Affected count
40872 25-count bottles
Manufactured in
73 Route 31 N, N/A, Pennington, NJ, United States
Products
MethylPREDNISolone Tablets, USP 8 mg, 25 tablets, Rx Only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India NDC 68382-917-11
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1453-2019Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief